Wells Fargo Downgrades OncoMed Pharmaceuticals (OMED) to Market Perform Following Acquisition Offer

Go back to Wells Fargo Downgrades OncoMed Pharmaceuticals (OMED) to Market Perform Following Acquisition Offer
ONCOMED PHARMA (NASDAQ: OMED) Delayed: 0.89 --0 (-0%)
Previous Close $0.89    52 Week High $23.98 
Open $16.48    52 Week Low $8.07 
Day High $0.89    P/E N/A 
Day Low $0.89    EPS $-1.00 
Volume 668